48 results
8-K
EX-1.1
CNTA
Centessa Pharmaceuticals plc
13 Sep 24
Centessa Pharmaceuticals Announces $150,000,000 Proposed Public Offering of American Depositary Shares
4:00pm
Agency and the UK Medicines & Healthcare products Regulatory Agency (collectively, the “Regulatory Authorities”), including, without limitation … healthcare programs, and the regulations promulgated pursuant to such statutes;
(iii) HIPAA, as amended by the Health Information Technology
8-K
CNTA
Centessa Pharmaceuticals plc
10 Jun 24
Departure of Directors or Certain Officers
7:13am
, investor relations and business development. Before Axovant, Dr. Weinhoff spent 15 years as an early-stage healthcare venture capitalist at CHL Medical … was a financial analyst in Morgan Stanley & Co.’s healthcare corporate finance group. Dr. Weinhoff holds an MD degree from Harvard Medical School, and MBA
8-K
EX-99.1
CNTA
Centessa Pharmaceuticals plc
10 Jun 24
Departure of Directors or Certain Officers
7:13am
and public financings. Before Axovant, Dr. Weinhoff spent 15 years as an early-stage healthcare venture capitalist at CHL Medical Partners, where he … & Co.’s healthcare corporate finance group.
About Centessa Pharmaceuticals
Centessa Pharmaceuticals plc is a clinical-stage pharmaceutical company
PRE 14A
8d7 mvxlv
26 Apr 24
Preliminary proxy
4:36pm
8-K
EX-1.1
alirp euxnwy
24 Apr 24
Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares
9:26am
8-K
jwnt958ra42r
8 Jul 22
Departure of Directors or Certain Officers
4:32pm
DEF 14A
yaec z4jl3
23 May 22
Definitive proxy
8:00am